Hudson Bay Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-417,000
Closed -$39.3M 812
2019
Q1
$39.3M Buy
+417,000
New +$36.5M 0.51% 36
2017
Q2
Sell
-76,000
Closed -$9.46M 931
2017
Q1
$9.46M Buy
76,000
+39,000
+105% +$4.67M 0.13% 168
2016
Q4
$4.28M Buy
+37,000
New +$4.12M 0.09% 223
2016
Q3
Sell
-25,000
Closed -$2.47M 571
2016
Q2
$2.47M Buy
+25,000
New +$2.59M 0.08% 169

Other funds holding CELG

Hudson Bay Capital Management's CELG Position: Q4 2019 in Review

Hudson Bay Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 614,744 shares — an estimated $61M sold.

Hudson Bay Capital Management first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $61M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hudson Bay Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hudson Bay Capital Management sold 614,744 Celgene Corp shares in Q4 2019, an estimated $61M.
  • Hudson Bay Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • Hudson Bay Capital Management's Celgene Corp position peaked at $61M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hudson Bay Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.